Thermo Fisher Scientific Launches First All-in-One, Fully Automated Sample Preparation System
28 October 2022 | Friday | News
Thermo Scientific EXTREVA ASE Accelerated Solvent Extractor enables true walk-away, sample-to-vial sample preparation allowing laboratories to increase throughput and staff efficiency
Thermo Scientific EXTREVA ASE Accelerated Solvent Extractor.
Laboratories performing environmental, food, and biopharmaceutical testing can now increase productivity, reduce errors, and minimize personnel time and solvent use with a new, all-in-one, automated chromatography sample preparation system.
The new Thermo Scientific EXTREVA ASE Accelerated Solvent Extractor is the first system to automatically extract and concentrate analytes of interest from solid and semi-solid samples, such as persistent organic pollutants (POPs), polycyclic aromatic hydrocarbons (PAHs) or pesticides, in a single instrument, eliminating manual sample transfer for a walk-away sample-to-vial workflow.
The system is also the first to perform four sample extractions and concentrations in parallel, significantly improving sample throughput and laboratory productivity. With manual intervention significantly reduced by a factor of three, in some cases, results can be more accurate and reliable—allowing users more time to focus on value-added tasks. Analytical labs extracting from solid or semi-solid matrices can pair the sample prep instrument with gas chromatography (GC), GC-mass spectrometry (MS) or liquid chromatography (LC)-MS systems.
The new Thermo Scientific EXTREVA ASE Accelerated Solvent Extractor is the first system to automatically extract and concentrate analytes of interest from solid and semi-solid samples, such as persistent organic pollutants (POPs), polycyclic aromatic hydrocarbons (PAHs) or pesticides, in a single instrument, eliminating manual sample transfer for a walk-away sample-to-vial workflow.
The system is also the first to perform four sample extractions and concentrations in parallel, significantly improving sample throughput and laboratory productivity. With manual intervention significantly reduced by a factor of three, in some cases, results can be more accurate and reliable—allowing users more time to focus on value-added tasks. Analytical labs extracting from solid or semi-solid matrices can pair the sample prep instrument with gas chromatography (GC), GC-mass spectrometry (MS) or liquid chromatography (LC)-MS systems.
“Traditional sample preparation for chromatography with solid or semi-solid samples is labor-intensive, prone to errors and can stifle lab productivity,” said Dino Alfano, vice president and general manager, ion chromatography and sample preparation, Thermo Fisher Scientific. “Even with current automation solutions, the process can involve time-consuming manual navigation of multiple instruments. By seamlessly performing sample extraction and evaporation of four samples in parallel, the EXTREVA ASE system redefines this cumbersome workflow. Streamlining workflows allows our customers to reduce manual sample preparation steps from hours to minutes, thereby increasing their productivity, minimizing errors, and dramatically reducing solvent use; ultimately helping them meet sustainability and cost goals.”
Matthew MacLennan, director, LC/MS/MS DevOps, Pacific Rim Laboratories, said, “We are looking to innovate our processes with technologies that will enable us to extract the most difficult and complex matrices with ease. EXTREVA ASE does just that for our POPs extractions.”
Matthew MacLennan, director, LC/MS/MS DevOps, Pacific Rim Laboratories, said, “We are looking to innovate our processes with technologies that will enable us to extract the most difficult and complex matrices with ease. EXTREVA ASE does just that for our POPs extractions.”
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
